The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Open accessAbstract
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest multicentre study to date (>3600 patients with HCM), syncope was an independent predictor of the composite of SCD and ICD discharge (hazard ratio 2.05, 95% CI 1.48-2.82). 350”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LVOT obstruction has been identified as a predictor of sudden death in some but not all studies”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“initially validated in 2013.”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citationPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Research works printed but not linked: 1
- 2012, Circulation: Arrhythmia and Electrophysiology, 6, 443
Cited by
Sorted by citations
Items 901–999 of 999
Trientine for hypertrophic cardiomyopathy: a phase 2 trial
Farrant, J. P., Dodd, S. R., Rosala‐Hallas, A., Vaughan, C., Spowart, C., Bedson, E., Clayton, D., Reid, A. B., Garratt, C. J., Raman, B., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag512 · Cited by 1
Pereira, J. C., Amador, R., Vieira, A., Carvalho, R. A., Castilho, B., Arteaga, E., Rochitte, C. E., Rocha, B. R., Lopes, P. M., Abecasis, J., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03779-6 · Cited by 1
Rowin, E. J., Maron, B. J., Siontis, K. C., Tower-Rader, A. F., Massera, D., Koethe, B. C., Bilen, O., Phelan, D., Arnold, A. D., Mohal, J. S., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078597 · Cited by 1
Self-citationWang, L., Zhang, H., Lu, G., Zhou, J., Lu, Z., Wang, L., Zhang, C., Ma, X., Li, S., & Zhao, L. (2026) · Insights into Imaging · doi:10.1186/s13244-026-02385-3 · Cited by 1
Mearns, B. M. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.169 · Cited by 1
Stress Echocardiography in Hypertrophic Cardiomyopathy
Olivotto, I., Nistri, S., & Picano, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20958-6_34 · Cited by 1
Oko‐Sarnowska, Z., Pyda, M., Trojnarska, O., Klisiewicz, A., Kukulski, T., Dziuk, M., & Płońska‐Gościniak, E. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0205 · Cited by 1
Predicting risk of sudden death in hypertrophic cardiomyopathy: Can additional simple markers help?
Brito, D. A. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.02.005 · Cited by 1
Hypertrophic Cardiomyopathy: Treatment, Risk Stratification, and Implantable Defibrillators
Magnusson, P. (2017) · InTech eBooks · doi:10.5772/65392 · Cited by 1
Rubiś, P., Biernacka-Fijałkowska, B., Khachatryan, L., Karabinowska, A., Faltyn, P., Dziewięcka, E. M., Wiśniowska‐Śmiałek, S., Pająk, L. T., & Podolec, P. S. (2017) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2017.1310843 · Cited by 1
Mort subite de l'adulte : étiologies et prévention
Waldmann, V., Bougouin, W., Sharifzadehgan, A., Marijon, É., & Jouven, X. (2017) · Cited by 1
Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy
Shen, Y., & Xu, C. (2017) · Medicine · doi:10.1097/md.0000000000008625 · Cited by 1
Bray, J. J. H., Bucciarelli‐Ducci, C., & Stuart, G. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223352 · Cited by 1
Multimodality Imaging for Hypertrophic Cardiomyopathy
Kaso, E. R., & Kramer, C. M. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00827-9 · Cited by 1
Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases
del Rincón, J. P. H., Conesa, M. C. O., Serrano, A. I. R., Pulgar, H. G., Cuenca, D. L., Muñoz‐Esparza, C., Peñalver, M. N., Mateo, J. J. S., Rocamora, E. N., Gil, C., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.634300 · Cited by 1
Self-citationBaxi, S. (2021) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/0609546 · Cited by 2
Hypertrophic Cardiomyopathy and Left Ventricular Non-Compaction
Cavigli, L., D’Ascenzi, F., Pelliccia, A., & Cecchi, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-80447-3_4 · Cited by 1
Mielczarek, S., Syska, P., Lewandowski, M., Kowalik, I., Pytkowski, M., & Szwed, H. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16206 · Cited by 1
von Scheidt, W., Klingenheben, T., & BOSCH, R. F. (2020) · Der Internist · doi:10.1007/s00108-020-00821-0 · Cited by 2
Hazeki, D., & Yoshinaga, M. (2021) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.37.255 · Cited by 1
Slivnick, J. A., Wali, E., & Patel, A. R. (2022) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-022-09571-z · Cited by 1
He, Y., Ma, H., Sun, N., Zeng, S., Zhang, Y., Shu, Y., Hua, W., Zhou, T., Zhou, L., & Li, X. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409267 · Cited by 1
Echocardiographic predictors of outcomes in hypertrophic cardiomyopathy
Franco, A. D., Pálinkás, E. D., Panichella, G., & Olivotto, I. (2023) · Exploration of Cardiology · doi:10.37349/ec.2023.00010 · Cited by 1
Lammers, S. S., Lawrenz, T., Lawin, D., Hoyer, A., Stellbrink, C., & Albrecht, U. (2023) · JMIR Research Protocols · doi:10.2196/52035 · Cited by 1
Novikova, Т. N., Bitakova, F. I., Ignateva, V., Novikov, V. I., Sayganov, S. A., & Shcherbakova, V. A. (2023) · Cardiac Arrhythmias · doi:10.17816/cardar567837 · Cited by 3
Jurubeba, A. K. X., Khanjar, A. S., Fraga, A. S., Dragalzew, D. C. D. C., Grion, J. M., Ribeiro, J. P. V., de Melo, N. M., & Xisto, R. A. D. N. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024264p145 · Cited by 1
Kommentar zu den Leitlinien 2023 der ESC zum Management von Kardiomyopathien
Meder, B., Eckardt, L., Falk, V., Klaassen, S., Klingenheben, T., Knebel, F., Schulze‐Bahr, E., & Schulz‐Menger, J. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00685-w · Cited by 1
Liebregts, M. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.011 · Cited by 1
Sex-related differences in the association between septal wall thickness and survival
Khoury, S., Zornitzki, L., Laufer‐Perl, M., Bhatia, R., Marwaha, S., Tome, M., Granot, Y. N., Perelman, M. G., Avivi, I., Shacham, Y., et al. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101427 · Cited by 1
Risk Factors of Cardiac Complications in Pregnant Women with Hypertrophic Cardiomyopathy
Tt, H., Feng, S. H., & Lin, J. (2024) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_62_24 · Cited by 1
CardioGraph: a platform to study variations associated with familiar cardiopathies
Alberto García, S., Costa, M., Perez, A., & Pastor, Ó. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02700-2 · Cited by 1
Treatment options for hypertrophic obstructive cardiomyopathy: a patient-centric review
Cirillo, C., Perillo, A., Monda, E., Palmiero, G., Verrillo, F., Rubino, M., Diana, G., Dongiglio, F., Caiazza, M., Cirillo, A., et al. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2436659 · Cited by 1
Self-citationTürkiye’de Tıp Eğitimi Müfredatlarında Yapay Zeka Derslerinin Durumunun Araştırılması
Gencer, K., & Gencer, G. (2024) · Bilgisayar Bilimleri ve Teknolojileri Dergisi · doi:10.54047/bibted.1520315 · Cited by 1
Alromaihi, M., Alrumaihi, F., Alwanian, W. M., Alharbi, H. O., AlDuayji, N. N., Alfifi, S. M., Al-Doaiss, A. A., Alshabrmi, F. M., Thornbury, W., & Khan, S. U. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103040 · Cited by 1
Norrish, G., Field, E., Cervi, E., & Kaski, J. P. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.1950 · Cited by 1
Ariza, J. A., & Bermúdez-Santana, C. I. (2025) · Springer eBooks · doi:10.1007/978-981-96-4585-5_13 · Cited by 1
Sudden cardiac death: Risk stratification using cardiac MRI
Domènech-Ximenos, B., Jiménez‐Arjona, R., Ortiz-Pérez, J. T., Perea, R. J., Sánchez, M., Prat, S., & Doltra, A. (2025) · Radiología (English Edition) · doi:10.1016/j.rxeng.2025.101639 · Cited by 2
Systolic Dyssynchrony Index in Hypertrophic Cardiomyopathy
Wang, R., Zhuang, H., Xu, N., Zhang, L., Xing, J., Zhang, T., Kang, L., Song, L., & Pang, K. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.05.002 · Cited by 1
Electrical Storm in Patients With Hypertrophic Cardiomyopathy
Groussin, P., Dezecot, M., Decaudin, D., Pavin, D., Ninni, S., Klein, C., Ollitrault, P., Champ-Rigot, L., Font, J., Costa, A. D., et al. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.06.035 · Cited by 1
Colan, S. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00036-5 · Cited by 1
Amano, M., Kitaoka, H., Yoshikawa, Y., Kubo, T., Sakata, Y., Dohi, K., Tokita, Y., Kato, T., Matsushima, S., Kitai, T., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0765 · Cited by 1
Cardiac Arrhythmias and Pacing 2015: A Selection of Topical Issues
Peinado, R., Ruiz‐Mateas, F., Izquierdo, M., Arana‐Rueda, E., Robledo, M. J. L., Arias, M. A., Jiménez‐Jáimez, J., Rodríguez‐Mañero, M., & Chimeno, J. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.11.005 · Cited by 1
Mort subite de l’adulte : une meilleure compréhension pour une meilleure prévention
Waldmann, V., Bougouin, W., Karam, N., Albuisson, J., Cariou, A., Jouven, X., & Marijon, É. (2017) · Journal Européen des Urgences et de Réanimation · doi:10.1016/j.jeurea.2017.10.003 · Cited by 1
Inherited Cardiovascular Conditions: Phenotype-Genotype Data Mining and Sharing, and Databases
van Tintelen, J. P., & van der Zwaag, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_31 · Cited by 1
Lanier, G. M., Fallon, J. T., & Naidu, S. S. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.010 · Cited by 1
Al-Shura, A. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817572-9.00001-x · Cited by 1
Risikoabschätzung bei reduzierter LV-EF mit Strain‑Echokardiographie
von Knobelsdorff, F. (2020) · Der Kardiologe · doi:10.1007/s12181-020-00381-5 · Cited by 1
Overlapping Phenotype of Cardiomyopathy in a Patient with Double Mutation: A Case Report
Glaveckaitė, S., Mikštienė, V., Preikšaitienė, E., Norvilas, R., Janavičius, R., & Valevičienė, N. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11010005 · Cited by 1
Cardiodesfibrilador implantable: estado del arte
Olaya-Sánchez, A., Rojas-Montañez, L. M., & Velásquez, J. D. (2022) · Revista Colombiana de Cardiología · doi:10.24875/rccar.m21000102 · Cited by 1
Modeling Biomechanics in the Healthy and Diseased Heart
Miller, R., Marlevi, D., Zhang, W., Hirschvogel, M., Hadjicharalambous, M., Capilnasiu, A., Balmus, M., Hager, S., Jilberto, J., Bonini, M., et al. (2021) · Nečas center series · doi:10.1007/978-3-030-88084-2_5 · Cited by 1
The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
Todurov, B. M., Kovtun, G. I., Khokhlov, A. V., Pantazi, O. V., Shpachuk, A. O., Melnik, A. Y., Максаков, А. О., & Batsiun, A. S. (2020) · Cardiac Surgery and Interventional Cardiology · doi:10.31928/2305-3127-2020.4.4449 · Cited by 1
Higuchi, S., Minami, Y., Shoda, M., & Hagiwara, N. (2021) · Japanese Journal of Electrocardiology · doi:10.5105/jse.41.64 · Cited by 1
Baksi, A. J., & Pennell, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-282-2.00013-5 · Cited by 1
Ruivo, C., Sá, F. M., Correia, J., Belo, A., Loureiro, M. F., & Morais, J. (2019) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2019.05.025 · Cited by 1
de Oliveira, G. M. M., Fontes‐Carvalho, R., Gonçalves, L. M. M., Cardim, N. M., & Rochitte, C. E. (2020) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2020.04.006 · Cited by 1
Sequeira, L., McNair, D., Wiljer, D., Strudwick, G., Luca, V. D., Kailasam, K., Thompson, M., Chou, B., & Strauss, J. (2022) · Studies in health technology and informatics · doi:10.3233/shti220140 · Cited by 1
Sridhar, S., Faisal, A., & Ratnani, I. (2023) · Acta Scientific Medical Sciences · doi:10.31080/asms.2023.07.1531 · Cited by 1
Choi, H., & Kim, H. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.07 · Cited by 1
Schindler, T. H., Valenta, I., & Jain, S. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100467 · Cited by 1
Miller, C., Lewis, G. A., & Ray, S. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.034 · Cited by 1
Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
Schindler, T. H., Brown, D., & Sadhu, J. S. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100512 · Cited by 1
Top Cats Often Begin as Underdogs: The Ascent of Trabecular Fractal Analysis with Cardiac MRI
Captur, G., & Moon, J. (2020) · Radiology · doi:10.1148/radiol.2020203800 · Cited by 1
Making Words Count with Computerised Identification of Hypertrophic Cardiomyopathy PatientsPreprint
Slater, L. T., Bradlow, W. M., Desai, T., Aziz, A., Evison, F., Ball, S. T., & Gkoutos, G. V. (2021) · medRxiv · doi:10.1101/2021.04.13.21255353 · Cited by 1
Marwick, T. H. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.06.008 · Cited by 1
Machine Learning and Big Data: An Approach Toward Better Healthcare Services
Sami, N., & Aziz, A. (2021) · doi:10.1002/9781119818717.ch1 · Cited by 1
Ventricular Arrhythmias and Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Cain, M. A., & Link, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99797-7 · Cited by 1
2017 Dr. Pedro Cossio Foundation Award
Lerman, J. (2018) · doi:10.7775/rac.v86.i.12909 · Cited by 1
Electronic Health Record Data in Cardiovascular Research
Sammani, A. Z. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1169 · Cited by 1
Roldan, P. C., Ravi, S., Hodovan, J., Belcik, R. T., Heitner, S. B., Masri, A., & Lindner, J. R. (2022) · Research Square · doi:10.21203/rs.3.rs-1670380/v1 · Cited by 1
Implantable cardioverted defibrillators: 40 years of history and beyond
Filippo, P. D., Malanchini, G., & Ferrari, P. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2098116 · Cited by 1
Abbasi, M. A., El-Am, E. A., Geske, J. B., & Herrmann, J. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.12.013 · Cited by 1
Marwick, T. H., & Chandrashekhar, Y. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.03.010 · Cited by 1
Rhee, T., & Kim, H. (2024) · Heart · doi:10.1136/heartjnl-2024-324208 · Cited by 1
Carrick, R. T., & Rowin, E. J. (2024) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2024.08.003 · Cited by 1
Do publications of machine learning models justify the enthusiasm they generate?
Bèze, N. E., & Azoulay, L.-D. (2024) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.24.06538-4 · Cited by 1
Septal Thickness as a Predictor for Appropriate ICD Shocks in Hypertrophic Cardiomyopathy PatientsPreprint
Danesh, S., Ahadi, M., & Nikoo, M. H. (2024) · Research Square · doi:10.21203/rs.3.rs-5391709/v1 · Cited by 1
Russell, M. W. W., & Meisner, J. K. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.04.007 · Cited by 1
Pediatric Diagnosis and Management
Colan, S. D. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4956-9_9
La importancia de la estratificación de riesgo de muerte súbita en la miocardiopatía hipertrófica
Moreno, M. M., Climent, V. E., García‐Honrubia, A., & Marín, F. R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.01.006
Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy. Response
Sarrias, A., Galve, E., Sabaté, X., & Villuendas, R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.02.007
Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy
Moreno, M. M., Climent, V. E., García‐Honrubia, A., & Marín, F. R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.01.004
Sarrias, A., Galve, E., Sabaté, X., & Villuendas, R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.02.007
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Tissue Doppler and Risk Stratification in Hypertrophic Cardiomyopathy
Monserrat, L. (2014) · doi:10.7775/ajc.82.2.4055
Self-citationCARDIOMIOPATIA HIPERTRÓFICA E MORTE SÚBITA CARDÍACA
Bibliográfica, A. D. R. (2014)
Syncope and sudden cardiac death: some answers to clinical challenges
Lüscher, T. F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw168
Gossios, T. D., Efthimiadis, G. K., Karamitsos, T. D., Zegkos, T., Athyros, V. G., & Karvounis, H. I. (2016) · The Open Hypertension Journal · doi:10.2174/1876526201608010001
Spirito, P., Autore, C., & Maron, B. J. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.006
Implantable Cardioverter-Defibrillators in Inherited Arrhythmia Syndromes
Nordkamp, L. R. A. O., & Wilde, A. A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00021-3
Peinado, R., Ruiz‐Mateas, F., Izquierdo, M., Arana‐Rueda, E., Robledo, M. J. L., Arias, M. A., & Chimeno, J. (2016)
Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers
Captur, G., & Moon, J. (2016) · Heart · doi:10.1136/heartjnl-2016-310331
Фролов, А. В., Vaikhanskaya, T. G., Мельникова, О. П., Павлович, В. А., & Gul’, L. M. (2016) · Annaly aritmologii · doi:10.15275/annaritmol.2016.2.3
Electrophysiology Updates in Adult Congenital Heart Disease
Lam, W. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-16-5902
Iacovoni, A., Quarta, G., & Senni, M. (2015) · Giornale italiano di cardiologia · doi:10.1714/1820.19820
Stroke and atrial fibrillation in hypertrophic cardiomyopathy
Guttmann, O. P. (2015) · UCL Discovery (University College London)
Pregnancy in Hypertrophic Cardiomyopathy
Michels, M. (2017) · Congenital heart disease in adolescents and adults · doi:10.1007/978-3-319-38913-4_11
Hypertrophic cardiomyopathy or hereditary hemochromatosis? (RCD code: III-2B.3.o)
Holcman, K., Rubiś, P., Wiśniowska‐Śmiałek, S., Leśniak‐Sobelga, A., Hlawaty, M., Kostkiewicz, M., & Podolec, P. S. (2016) · Journal of Rare Cardiovascular Diseases · doi:10.20418/jrcd.vol3no1.264
Kłopotowski, M. M., Jasińska, A., Jarmus, E., Śpiewak, M., Jamiołkowski, J., Kwapiszewska, A., Baranowski, R., & Małek, Ł. A. (2016) · Heart Beat Journal · doi:10.24255/hbj/66497
Genetische Arrhythmiesyndrome – Teil 2
Beckmann, B.-M., Curta, A., & Kääb, S. (2017) · Kardiologie up2date · doi:10.1055/s-0042-122794
Metadata
- Authors
- O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
- Affiliations
- University College London (GB)
- National and Kapodistrian University of Athens (GR)
- University of Bologna (IT)
- Hospital Universitario Virgen de la Arrixaca (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- University College Hospital at Westmoreland Street (GB)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-14
- Volume
- 35
- Issue
- 30
- Pages
- 2010-2020
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2119361626
- Cited by
- 1,251
- References
- 50
- Citations by year
- 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
- FWCI
- 39.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hispana (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0509-10230)
- Università di Bologna
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
- MeSH terms
- Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
